Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients (vol 33, pg 1745, 2017)

被引：1
|
作者：
Deitelzweig, S.
Luo, X.
Gupta, K.
Trocio, J.
Mardekian, J.
Curtice, T.
Lingohr-Smith, M.
Menges, B.
Lin, J.
机构：
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2018年 / 34卷 / 01期
关键词：
D O I：
10.1080/03007995.2017.1397989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [41] Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation
    Sogaard, Mette
    Ording, Anne Gulbech
    Skjoth, Flemming
    Larsen, Torben Bjerregaard
    Nielsen, Peter Bronnum
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (02) : 137 - 146
  • [42] Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for the Prevention of Stroke: An Analysis of Patients with Atrial Fibrillation in Greece (vol 16, pg A525, 2013)
    Athanasakis, K.
    Arzoumanidou, D.
    Karampli, E.
    Armelidou, E.
    Giovas, P.
    Petrikkou, E.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2014, 17 (02) : 305 - 305
  • [43] Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants
    Baker, Christine L.
    Dhamane, Amol D.
    Rajpura, Jigar
    Mardekian, Jack
    Dina, Oluwaseyi
    Russ, Cristina
    Rosenblatt, Lisa
    Lingohr-Smith, Melissa
    Lin, Jay
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [44] Effectiveness and Safety of Apixaban and Rivaroxaban Versus Warfarin for the Secondary Prevention of Stroke or Systemic Embolism Among Nonvalvular Atrial Fibrillation Patients
    Coleman, Craig
    Bunz, Thomas
    NEUROLOGY, 2017, 88
  • [45] EFFECTIVENESS AND SAFETY OF APIXABAN AND RIVAROXABAN VERSUS WARFARIN FOR THE SECONDARY PREVENTION OF STROKE OR SYSTEMIC EMBOLISM AMONG NONVALVULAR ATRIAL FIBRILLATION PATIENTS
    Coleman, Craig I.
    Bunz, Thomas J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 458 - 458
  • [46] Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population
    Amin, A.
    Keshishian, A.
    Zhang, Q.
    Dina, O.
    Dhamane, A.
    Nadkarni, A.
    Carda, E.
    Liu, X.
    Rosenblatt, L.
    Baser, O.
    Baker, C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1005 - 1005
  • [47] Comparison of serious adverse events in very elderly Asian atrial fibrillation patients with or without anticoagulation therapy: direct oral anticoagulants vs. warfarin vs. non-anticoagulants
    Sakamoto, A.
    Okawa, K.
    Hara, S.
    Taya, S.
    Sudo, Y.
    Sogo, M.
    Ugawa, S.
    Okada, T.
    Nosaka, K.
    Takahashi, M.
    Sakane, K.
    Doi, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 486 - 486
  • [48] Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms
    Eryne E. Wiethorn
    Carolyn Magee Bell
    Barbara S. Wiggins
    American Journal of Cardiovascular Drugs, 2021, 21 : 545 - 551
  • [49] Anticoagulation Challenges in Hematogeriatrics: Effectiveness and Safety of Direct Oral Anticoagulants Vs Vitamin k Antagonist in Elderly with Atrial Fibrillation
    Campoy, Desiree
    Artaza, Gonzalo
    Velasquez, Cesar A.
    Canals, Tania
    Johansson, Erik A.
    Flores, Katia
    Bastidas, Gabriela
    Ruiz, Silvia
    Ene, Gabriela S.
    Comai, Alessandra
    Subira, Maricel
    Salinas, Ramon
    Sierra, Jorge
    Olivera, Pavel E.
    BLOOD, 2019, 134
  • [50] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin among nonvalvular atrial fibrillation patients with prior bleeding events
    Lip, G. Y. H.
    Keshishian, A.
    Kang, A.
    Luo, X.
    Atreja, N.
    Zhang, Y.
    Schuler, P.
    Jiang, J.
    Lovett, K.
    Yuce, H.
    Deitelzweig, S.
    EUROPEAN HEART JOURNAL, 2021, 42 : 571 - 571
12345